After a 2023 study linked GLP-1s to an increased risk for pancreatitis, gastroparesis, and bowel obstruction, other researchers did a retrospective study to reexamine the association.
UBC medical student Mohit Sodhi named one of Forbes's "30 Under 30" in Healthcare thelinkpaper.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelinkpaper.ca Daily Mail and Mail on Sunday newspapers.
New research links weight loss medications like Ozempic and Wegovy to a greater risk of pancreatitis, gastroparesis, and bowel obstruction. Patients who are losing a more extreme amount of body weight are more at risk for these severe side effects.